home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

Advancing the Science of Drug Discovery: Academic & Industrial Perspectives

 
  November 20, 2006  
     
 
Society for Biomolecular Sciences, Palais de Congre de Montreal, Canada
April 15-19, 2007


After the Society's most successful annual event in Seattle this year, professionals from around the globe will want to participate in the next SBS Annual Conference & Exhibition in April 2007. This will be the first spring annual the Society has scheduled. The SBS event, the premier scientific and showcase event in molecular discovery, brings together more than 2,900 professionals, offering a unique opportunity to learn more about the latest innovations, technologies, and research in the drug discovery sciences from all over the world. Session topics include: · Advances in Screening Technologies · Biomarkers: From Bench to Clinic · Compound Management: Challenges & Automation Solutions · Enzyme Targets: Black Box or Whole Cell Assays? · From Gene to Target: Functional Target Validation Strategies · High-Content Cellular Screening · Immunotherapeutics, mAbs & Translational Medicine · Structural Biology: Underpinning Drug Discovery · Systems Biology & High-Throughput Approaches to Screening Native Cells · Target Biology & Screening: GPCRs · Target Biology & Screening: Ion Channels · Toxicity Profiling Using High-Throughput & High-Content Technologies Contact: Marietta Manoni, CMP Conference Manager mmanoni@sbsonline.org
 
 
Organized by: Society for Biomolecular Sciences
Invited Speakers: Julian Davies is Emeritus Professor of Microbiology and Immunology at the University of British Columbia; he was recently Director of the UBC Life Sciences Institute. He was trained as an organic chemist in Britain, but in 1962, he discovered microbiology. The title of his presentation is “Everyone depends on everyone else.”

Dr. Larry Gold is currently the Chief Executive Officer, Chief Science Officer and Chairman of the Board of SomaLogic, Inc.

Dr. Eugene C. Butcher is a Professor in the Department of Pathology at Stanford University, a staff physician of the Palo Alto Veterans Affairs Health Care System, and co-founder and Chair of the Scientific Advisory Board of Bioseek, Inc.
Tentative title is: "Human cell systems biology for drug discovery: applications to drug innovation and development from screening to clinical indication selection."


 
Deadline for Abstracts: January 26, 2007
 
Registration: http://www.sbsonline.org/
E-mail: mmanoni@sbsonline.org
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.